117 related articles for article (PubMed ID: 23235720)
1. Differences in CD44s expression in HNSCC tumours of different areas within the oral cavity.
Krump M; Ehrmann J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):280-3. PubMed ID: 23235720
[TBL] [Abstract][Full Text] [Related]
2. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
Wang SJ; Earle C; Wong G; Bourguignon LY
Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
[TBL] [Abstract][Full Text] [Related]
3. The potential of CD44 as a diagnostic and prognostic tool in oral cancer.
Emich H; Chapireau D; Hutchison I; Mackenzie I
J Oral Pathol Med; 2015 Jul; 44(6):393-400. PubMed ID: 25640063
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers in stage I oral cavity squamous cell carcinoma.
Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
[TBL] [Abstract][Full Text] [Related]
5. Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity.
Boldrup L; Coates PJ; Laurell G; Nylander K
Oral Oncol; 2011 Sep; 47(9):861-5. PubMed ID: 21802344
[TBL] [Abstract][Full Text] [Related]
6. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
7. CD44s and CD44v6 expression in head and neck epithelia.
Mack B; Gires O
PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
[TBL] [Abstract][Full Text] [Related]
8. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
9. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.
Sand JP; Kokorina NA; Zakharkin SO; Lewis JS; Nussenbaum B
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):245-50. PubMed ID: 24247005
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas.
Stoll C; Baretton G; Soost F; Terpe HJ; Domide P; Löhrs U
Oral Oncol; 1999 Sep; 35(5):484-9. PubMed ID: 10694948
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
[TBL] [Abstract][Full Text] [Related]
14. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
Zargaran M
Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
[TBL] [Abstract][Full Text] [Related]
15. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
16. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
18. Site-specific gene expression patterns in oral cancer.
Frohwitter G; Buerger H; Korsching E; van Diest PJ; Kleinheinz J; Fillies T
Head Face Med; 2017 May; 13(1):6. PubMed ID: 28486965
[TBL] [Abstract][Full Text] [Related]
19. Glycogen-Rich Clear Cell Squamous Cell Carcinoma Originating in the Oral Cavity.
Khoury ZH; Bugshan A; Lubek JE; Papadimitriou JC; Basile JR; Younis RH
Head Neck Pathol; 2017 Dec; 11(4):552-560. PubMed ID: 28342060
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas.
Rodrigo JP; Dominguez F; Alvarez C; Herrero A; Suarez C
Am J Otolaryngol; 2003; 24(6):384-9. PubMed ID: 14608570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
